HIV/AIDS linked to extensively drug resistant TB
A highly drug-resistant form of tuberculosis (TB) has been linked to HIV/AIDS in a study conducted in rural South Africa by researchers at Yale School of Medicine. TB is the m...New bird, bat species revealed by extensive DNA barcode studies
To Robert C. von Borstel, cancer is a metaphorical example of the perfect invasion by a founder species. Like the first pregnant finch that landed on a deserted island in the Galapagos Archipelago, the first cancer cell in the human body has to undergo many mutations through many generations to establish itself as an invader of different organs in the body. But once it is there, like any newly st...Extensive Campaigning To Warn Against Children’s Growing Affinity To Fast Food In Britai
It is now a big global problem, the entire world is struggling against the ever expanding love of burgers and pizzas among children as opposed to traditional foods.Eating patterns are undergoing a sea change//. And the older experienced generations are worried about this fast food generation growing up. The same fear has prompted a British heart charity to launch a poster campaign to...Extensive Academic Work Envisaged On Effects of Smoking Ban
From the dot of 0600 GMT on Sunday, smoking ban in enclosed public places will be activated. Scotland will also play host to one of the largest studies// in the world that will probe the impact of smoking ban on the health of bar staff. The study, budgeted at a mammoth £140,000, will be funded by NHS Health Scotland, and will be conducted by Aberdeen University researchers, who will s...Geisinger Launches Extensive Study on Obesity and Related Liver Problem
Relying on one of the largest collections of liver tissue samples ever acquired by a single organization, Geisinger Health System researchers have embarked on a massive study// of one of the fastest growing liver problems. Nonalcoholic fatty liver disease starts with the accumulation of fat on the liver, which leads to inflammation and scarring. It can progress to the point of permanent...Extensive Clinical Data on Erbitux Presented at the 2007 ASCO Annual Meeting
NEW YORK--(BUSINESS WIRE)--Jun 5, 2007 - ERBITUX (cetuximab), thefirst approved IgG1 monoclonal antibody targeting the epidermalgrowth factor receptor (EGFR) developed and commercialized byImClone Systems Incorporated, was the focus of nine oral and 46poster presentations at the recently concluded 43rd Annual Meetingof the American Society of Clinical Oncology (ASCO). This year's ASCO ERB...ImClone Systems Showcases Extensive Research and Development Program at the AACR Annual Meeting
NEW YORK--(BUSINESS WIRE)--Apr 19, 2007 - IgG1 monoclonalantibodies developed by ImClone Systems Incorporated (NASDAQ: IMCL)were the focus of 44 total presentations at the recently concluded98th Annual Meeting of the American Association for Cancer Research(AACR), including seven oral presentations and 37 posters. Important ERBITUX(R) (cetuximab) clinical data were the focus oftwo back-to...